KRAS activation in colorectal cancer is associated with the upregulation of downstream genes such as BCL2, H2AFZ, RAP1B, TBX19, E2F4, and MMP1, many of which are being investigated as markers of clinical progression [65]. Here, KRAS is linked to colorectal cancer.